European perspective on the costs and benefits of molecular diagnostics

Molecular Diagnostics constitute an essential aspect of the move toward personalised medicine. However, despite their promises, few molecular diagnostics are used in clinical practice today, especially in Europe. In the webinar, we will discuss the hurdles that exist when it comes to rewarding the value of molecular diagnostics.

We will also review specific issues relating to some of the reimbursement systems. We will finally discuss how, moving forward, we can improve and accelerate patients’ access to innovative molecular diagnostics